Skip to main content
TipRanks
Go Ultimate75% OFF

iX Biopharma Ltd. (42C) Share Forecast & Price Target

26 Followers
See the Price Targets and Ratings of:

42C Analyst Ratings

Strong Buy
3Ratings
3Buy0Hold0Sell
Based on 3 analysts giving stock ratings to iX Biopharma Ltd. in the past 3 months

42C Stock 12 Month Forecast

S$1.03▲(126.37% Upside)
Based on 3 Wall Street analysts offering 12 month price targets for iX Biopharma Ltd. in the last 3 months. The average price target is SGD 1.03 with a high forecast of SGD 1.17 and a low forecast of SGD 0.92. The average price target represents a 126.37% change from the last price of SGD 0.46.
Highest Price TargetS$1.17Average Price TargetS$1.03Lowest Price TargetS$0.92

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for SG:42C
Price TargetArticle
OCBC Investment Analyst forecast on SG:42CUnknown AnalystNot RankedOCBC InvestmentS$0.92buy102.20%UpsideReiterated10/26/26
KGI Securities Analyst forecast on SG:42CUnknown AnalystNot RankedKGI SecuritiesS$1.17buy157.14%UpsideReiterated10/12/26
Phillip SecuritiesS$1buy119.78%UpsideReiterated09/08/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
OVIDOvid Therapeutics
PTGXProtagonist Therapeutics
IMUXImmunic
IVAInventiva
PALIPalisade Bio

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering iX Biopharma Ltd.

3 Months
Paul Chew
Paul ChewPhillip Securities
Success Rate2/4 ratings generated profit
50%
Average Return
+1.93%

Copying Paul Chew's trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +1.93% per trade.

1 Year
Paul Chew
Paul ChewPhillip Securities
Success Rate2/4 ratings generated profit
50%
Average Return
-6.95%

Copying Paul Chew's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of -6.95% per trade.

2 Years
Paul Chew
Paul ChewPhillip Securities
Success Rate2/4 ratings generated profit
50%
Average Return
-10.82%

Copying Paul Chew's trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of -10.82% per trade.

42C Analyst Recommendation Trends

01234Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for 42C
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy01243
Buy00000
Hold00000
Sell00000
Strong Sell00000
total01243

In the current month, 42C has received 3 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 42C average Analyst price target in the past 3 months is 1.03.

42C Financial Forecast

S$-2S$-1.5S$-1S$-0.5S$0Q3 2026Q1 2027Q2 2027
ConsensusS$-0.00

42C Earnings Forecast

Next quarter’s earnings estimate for 42C is SGD 0.00 with a range of ― to ―. The previous quarter’s EPS was SGD 0.00. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

S$1.6MS$2MS$2.4MS$2.8MS$3.2MQ3 2026Q1 2027Q2 2027
ConsensusS$2.71M

42C Sales Forecast

Next quarter’s sales forecast for 42C is SGD 2.71M with a range of ― to ―. The previous quarter’s sales results were SGD 2.71M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

42C Stock Forecast FAQ

What is SG:42C’s average 12-month price target, according to analysts?
Based on analyst ratings, iX Biopharma Ltd.’s 12-month average price target is S$1.03.
What is SG:42C’s upside potential, based on the analysts’ average price target?
iX Biopharma Ltd. has 126.37% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is iX Biopharma Ltd. a Buy, Sell or Hold?
iX Biopharma Ltd. has a consensus rating of Strong Buy, which is based on 3 buy ratings, 0 hold ratings and 0 sell ratings.
What is iX Biopharma Ltd.’s share price target?
The average share price target for iX Biopharma Ltd. is S$1.03. This is based on 3 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is S$1.17, and the lowest forecast is S$0.92. The average share price target represents a 126.37% increase from the current price of S$0.455.
What do analysts say about iX Biopharma Ltd.?
iX Biopharma Ltd.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 3 Wall Street analysts.
How can I buy shares of iX Biopharma Ltd.?
To buy shares of SG:42C, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.